GE HealthCare Technologies Inc. is seeing a significant rise in its stock price, thanks to positive analyst sentiment and strategic developments.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is up today, gaining 2.79% to close at CA$66.62. This increase follows a series of analyst upgrades and exciting developments within the company that have caught investor attention.
Advertisement
GE HealthCare Technologies Inc.
GEHC.US
GEHC.US
GE HealthCare Technologies Inc.
WealthAwesomeMarket cap
$29.69B
P/E
15.1x
Div. yield
0.22%
Div. / share
$0.14
52W high
$89.64
52W low
$58.72
1W change
-1.56%
Beta
0.85
Analyst Price Targets
Based on 20 analysts covering GEHC · as of Oct 5, 2026
Wall Street analysts forecast GEHC stock price to rise 26.3% over the next 12 months.
Consensus
Buy4.25 / 5.00
Avg. Target
C$83.05
+26.3% Upside
Current Price
C$65.74
Last close
Analyst Breakdown (20 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
19.5%
Annualized
90-Day Vol
34.6%
Annualized
Trend (90d)
+6.9%
Annualized drift
90d Mean
C$67.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$66.28 | C$61.97 – C$70.90 |
| 60 trading days | C$66.83 | C$60.77 – C$73.51 |
| 90 trading days | C$67.39 | C$59.98 – C$75.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are reacting positively to GE HealthCare's recent strategic moves and analyst upgrades, indicating a potential shift in sentiment for the company.
GE HealthCare's stock rises 2.79%
The stock's rise today comes after a tough period, where it has seen a year-to-date decline of 21.75%.
Bull case
The recent coverage initiation by Needham, which includes a Buy rating and a price target of $93, suggests strong upside potential. The launch of CareIntellect, an AI tool designed to improve hospital operations, could boost revenue and profitability over time.
Bear case
Despite today's gains, GE HealthCare has faced considerable downward pressure in recent months, with a 30-day share price return down 13.38%. Concerns about execution risks and market conditions continue to pose challenges that could affect long-term growth.
Analyst Upgrades Boost Sentiment
Advertisement
The stock's recent rise is largely due to a Buy rating initiation by Needham, which set a price target of $93. Analysts believe that GE HealthCare's current stock price does not reflect its potential, creating an attractive risk/reward scenario for investors.
Strategic Developments in AI
GE HealthCare's launch of CareIntellect, an AI-powered tool designed to predict hospital capacity constraints, is expected to improve operational efficiency and revenue generation. This move aligns with the growing trend of integrating AI into healthcare solutions, positioning GE HealthCare favorably in the market.
Market Context and Future Outlook
While GE HealthCare is having a positive day, the broader market context remains mixed. Investors are cautious due to the company's recent performance and ongoing challenges in the healthcare sector. However, if the company can effectively implement its strategies, there may be significant upside potential.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
